Form DEFA14A Emergent BioSolutions
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
Emergent BioSolutions Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
On April 27, 2026, Emergent BioSolutions Inc. published the following information on LinkedIn and X.
LinkedIn/X
April 27, 2026
Join us Wednesday at 9:00 a.m. Eastern Time for Emergent’s virtual annual meeting of stockholders via this link: www.virtualshareholdermeeting.com/EBS2026.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Long Beach Educator Bridget Gengler Releases New Children’s Book Inspired By Her Students
- Ninepoint Refiles Annual Management Reports of Fund Performance for Five HighShares ETFs
- Qtonic Quantum Releases Report on Football Data Security
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
